Lacuna Diagnostics Welcomes Full-Time Chief Medical Officer

MJH_7320.jpg

Eric J. Fish, DVM, PhD, DACVP officially started as full-time Chief Medical Officer and head of pathology at Lacuna Diagnostics, Inc on July 1st. Prior to being CMO, he was a tenure-track Assistant Professor of Veterinary Clinical Pathology at the Auburn University College of Veterinary Medicine and Owner/CEO of the digital pathology consulting company CytoVetStat, LLC. He recently graduated with his PhD in cancer biology (Dissertation: “microRNA as Predictive Biomarkers of Canine Mammary Tumors”).

Eric has been involved with Lacuna since fall 2017 when he helped design and run the multicenter proof-of-concept research study on their pilot digital cytology product, Lacuna 360 (Blanchet et al. “Evaluation of Region of Interest Digital Cytology Compared to Light Microscopy for Veterinary Medicine.” Vet Pathol. 2019 May 21:300985819846874. doi: 10.1177/0300985819846874). You can read more about that study here: https://www.ncbi.nlm.nih.gov/pubmed/31113293. He has also been actively involved in reading cases and growing the business over the past two years.

Dr. Fish wears many hats as Lacuna CMO: In addition to reading cases, he recruits, trains and manages pathologists; creates hospital protocols and works hand-in-hand with the other founders to build new features in the platform; leads medical Quality Assurance for Lacuna; and supervises research initiatives into machine learning for digital pathology.

We are thrilled to welcome Dr. Fish as a full-time member of our team. This marks a pivotal step forward as we work on exciting different ways to advance veterinary clinical pathology. Leaving his tenure-track position to join us full time in this journey is another vote of confidence in Lacuna and our team.

We continue to be motivated by the kind words from veterinarians about how digital cytology is changing the way they practice medicine. With Dr. Fish full time, we are also excited about creating flexible, collaborative, and extremely rewarding work opportunities for more pathologists worldwide.